AR015225A1 - CEPAS DE LEVADURA MODIFICADA QUE TIENEN EL GEN ATF2 INTERRUMPIDO, Y PROCEDIMIENTO DE OXIDACIoN IN VIVO DE UN SUSTRATO ELEGIDO ENTRE UN ESTEROIDE ENDoGENO, UN ESTEROL EXoGENO O UN ESTEROIDE EXoGENO. - Google Patents
CEPAS DE LEVADURA MODIFICADA QUE TIENEN EL GEN ATF2 INTERRUMPIDO, Y PROCEDIMIENTO DE OXIDACIoN IN VIVO DE UN SUSTRATO ELEGIDO ENTRE UN ESTEROIDE ENDoGENO, UN ESTEROL EXoGENO O UN ESTEROIDE EXoGENO.Info
- Publication number
- AR015225A1 AR015225A1 ARP990100487A ARP990100487A AR015225A1 AR 015225 A1 AR015225 A1 AR 015225A1 AR P990100487 A ARP990100487 A AR P990100487A AR P990100487 A ARP990100487 A AR P990100487A AR 015225 A1 AR015225 A1 AR 015225A1
- Authority
- AR
- Argentina
- Prior art keywords
- steroid
- exogen
- sterol
- substrate
- vivid
- Prior art date
Links
- 229930182558 Sterol Natural products 0.000 title abstract 3
- 150000003431 steroids Chemical class 0.000 title abstract 3
- 150000003432 sterols Chemical class 0.000 title abstract 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000758 substrate Substances 0.000 title abstract 2
- 230000003721 exogen phase Effects 0.000 title 2
- 101100026251 Caenorhabditis elegans atf-2 gene Proteins 0.000 title 1
- 101150003525 atf-2 gene Proteins 0.000 title 1
- 230000003647 oxidation Effects 0.000 title 1
- 238000007254 oxidation reaction Methods 0.000 title 1
- 235000003702 sterols Nutrition 0.000 abstract 2
- 230000004075 alteration Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000006213 oxygenation reaction Methods 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9801329A FR2774393B1 (fr) | 1998-02-05 | 1998-02-05 | Souches de levure ayant le gene atf2 interrompu et leurs applications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015225A1 true AR015225A1 (es) | 2001-04-18 |
Family
ID=9522616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990100487A AR015225A1 (es) | 1998-02-05 | 1999-02-05 | CEPAS DE LEVADURA MODIFICADA QUE TIENEN EL GEN ATF2 INTERRUMPIDO, Y PROCEDIMIENTO DE OXIDACIoN IN VIVO DE UN SUSTRATO ELEGIDO ENTRE UN ESTEROIDE ENDoGENO, UN ESTEROL EXoGENO O UN ESTEROIDE EXoGENO. |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US6218139B1 (enExample) |
| EP (1) | EP0977868B1 (enExample) |
| JP (1) | JP4443636B2 (enExample) |
| KR (1) | KR100599346B1 (enExample) |
| CN (1) | CN1201008C (enExample) |
| AR (1) | AR015225A1 (enExample) |
| AT (1) | ATE271610T1 (enExample) |
| AU (1) | AU748129B2 (enExample) |
| BR (1) | BR9904771A (enExample) |
| CA (1) | CA2285686C (enExample) |
| CZ (1) | CZ299506B6 (enExample) |
| DE (1) | DE69918752T2 (enExample) |
| DK (1) | DK0977868T3 (enExample) |
| EA (1) | EA004629B1 (enExample) |
| ES (1) | ES2221353T3 (enExample) |
| FR (1) | FR2774393B1 (enExample) |
| HR (1) | HRP990303B1 (enExample) |
| HU (1) | HU226657B1 (enExample) |
| ID (1) | ID22741A (enExample) |
| IL (1) | IL132151A (enExample) |
| ME (1) | ME00670B (enExample) |
| PL (1) | PL198376B1 (enExample) |
| PT (1) | PT977868E (enExample) |
| RS (1) | RS49619B (enExample) |
| SI (1) | SI0977868T1 (enExample) |
| SK (1) | SK286279B6 (enExample) |
| TR (1) | TR199902457T1 (enExample) |
| UA (1) | UA72438C2 (enExample) |
| WO (1) | WO1999040203A1 (enExample) |
| ZA (1) | ZA99676B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2799206A1 (fr) * | 1999-10-05 | 2001-04-06 | Transgene Sa | Procede de production de steroides modifies par fermentation de levures |
| FR2812884B1 (fr) * | 2000-08-08 | 2002-11-08 | Aventis Pharma Sa | Levures modifiees et utilisations, notamment pour la production de derives steroidiens |
| FR2820145B1 (fr) * | 2001-01-31 | 2004-01-23 | Aventis Pharma Sa | Souche de levure produisant des steroides de facon autonome |
| CA2548140A1 (en) | 2003-12-05 | 2005-06-23 | University Of Massachusetts | Oligosaccharide compositions and use thereof in the treatment of infection |
| FR2869914B1 (fr) | 2004-05-06 | 2012-11-09 | Aventis Pharma Sa | Souches de levure produisant du cholesterol et leurs applications |
| CN102604847B (zh) * | 2012-03-23 | 2013-05-15 | 天津科技大学 | 一株含有Lg-ATF1基因的酿酒酵母工程菌 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6447380A (en) * | 1987-08-19 | 1989-02-21 | Agency Ind Science Techn | Steroid-oxidizing yeast strain |
| EP0340878B1 (en) * | 1988-05-06 | 2001-05-16 | Aventis Pharma S.A. | Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor |
| FR2678611B1 (fr) | 1991-07-04 | 1995-01-20 | Roussel Uclaf | Nouveaux esters pyrethrinouides de l'alcool 1,3,4,5,6,7-hexahydro 1,3-dioxo-2h-isoindol-2-yl-methylique, leur procede de preparation et leur application comme pesticides. |
| JP3363197B2 (ja) * | 1992-06-18 | 2003-01-08 | 麒麟麦酒株式会社 | アルコールアセチルトランスフェラーゼ遺伝子およびその利用 |
| IL162476A (en) * | 1995-02-15 | 2005-12-18 | Aventis Pharma Sa | Arabidopsis thaliana proteins having delta -5,7- sterol - delta -7- reductase activity |
| JP4093598B2 (ja) * | 1995-03-14 | 2008-06-04 | 大関株式会社 | 新規なアルコールアセチルトランスフェラーゼ遺伝子 |
| FR2743829A1 (fr) * | 1996-01-19 | 1997-07-25 | Hydroplus | Hausse automatique pour ouvrage hydraulique tel que seuil en riviere, deversoir sur un barrage ou sur une digue de protection |
-
1998
- 1998-02-05 FR FR9801329A patent/FR2774393B1/fr not_active Expired - Lifetime
-
1999
- 1999-01-28 ZA ZA9900676A patent/ZA99676B/xx unknown
- 1999-02-01 US US09/243,367 patent/US6218139B1/en not_active Expired - Lifetime
- 1999-02-04 WO PCT/FR1999/000237 patent/WO1999040203A1/fr not_active Ceased
- 1999-02-04 ID IDW991153A patent/ID22741A/id unknown
- 1999-02-04 DE DE69918752T patent/DE69918752T2/de not_active Expired - Lifetime
- 1999-02-04 ME MEP-1999-497A patent/ME00670B/me unknown
- 1999-02-04 EA EA199900903A patent/EA004629B1/ru not_active IP Right Cessation
- 1999-02-04 CN CNB998004634A patent/CN1201008C/zh not_active Expired - Lifetime
- 1999-02-04 CZ CZ0351299A patent/CZ299506B6/cs not_active IP Right Cessation
- 1999-02-04 EP EP99901708A patent/EP0977868B1/fr not_active Expired - Lifetime
- 1999-02-04 HU HU0002858A patent/HU226657B1/hu unknown
- 1999-02-04 AU AU21714/99A patent/AU748129B2/en not_active Expired
- 1999-02-04 PL PL336301A patent/PL198376B1/pl unknown
- 1999-02-04 CA CA002285686A patent/CA2285686C/fr not_active Expired - Lifetime
- 1999-02-04 TR TR1999/02457T patent/TR199902457T1/xx unknown
- 1999-02-04 KR KR1019997009076A patent/KR100599346B1/ko not_active Expired - Lifetime
- 1999-02-04 SI SI9930668T patent/SI0977868T1/xx unknown
- 1999-02-04 ES ES99901708T patent/ES2221353T3/es not_active Expired - Lifetime
- 1999-02-04 PT PT99901708T patent/PT977868E/pt unknown
- 1999-02-04 RS YUP-497/99A patent/RS49619B/sr unknown
- 1999-02-04 BR BR9904771A patent/BR9904771A/pt not_active Application Discontinuation
- 1999-02-04 HR HR990303A patent/HRP990303B1/xx not_active IP Right Cessation
- 1999-02-04 IL IL132151A patent/IL132151A/en not_active IP Right Cessation
- 1999-02-04 JP JP54009599A patent/JP4443636B2/ja not_active Expired - Lifetime
- 1999-02-04 DK DK99901708T patent/DK0977868T3/da active
- 1999-02-04 SK SK1331-99A patent/SK286279B6/sk not_active IP Right Cessation
- 1999-02-04 AT AT99901708T patent/ATE271610T1/de active
- 1999-02-05 AR ARP990100487A patent/AR015225A1/es active IP Right Grant
- 1999-04-02 UA UA99116075A patent/UA72438C2/uk unknown
-
2001
- 2001-03-01 US US09/797,239 patent/US6503749B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Turrens et al. | Mitochondrial generation of oxygen radicals during reoxygenation of ischemic tissues | |
| Rapoport et al. | Electron leakage from the adrenal-cortex mitochondrial P450Scc and P450C11 systems: NADPH and steroid dependence | |
| AR015225A1 (es) | CEPAS DE LEVADURA MODIFICADA QUE TIENEN EL GEN ATF2 INTERRUMPIDO, Y PROCEDIMIENTO DE OXIDACIoN IN VIVO DE UN SUSTRATO ELEGIDO ENTRE UN ESTEROIDE ENDoGENO, UN ESTEROL EXoGENO O UN ESTEROIDE EXoGENO. | |
| ES2184364T3 (es) | Agente desinfectante acuoso que contiene acido performico y acido peracetico, procedimiento para su preparacion y su utilizacion. | |
| FR2844711B1 (fr) | Composition pour la teinture d'oxydation des fibres keratiniques humaines | |
| NO20032912D0 (no) | Beskyttelse, gjenoppbygging og styrking av erytropoietinresponsive celler,vev og organer | |
| ES2058515T3 (es) | Composicion enzimatica detergente y blanqueante. | |
| Cheng et al. | Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species | |
| MX9702041A (es) | Intensificadores tales como la acetosiringona. | |
| AR032392A1 (es) | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. | |
| DK1082410T3 (da) | Humane CD45 - og/eller fibroblast mesenchymale stamceller | |
| EP0433854A3 (en) | 3-aminopyrazolo heterocycles, their use for the determination of hydrogen peroxide, hydrogen peroxide forming systems, peroxidase, peroxidant active substances or electron rich aromatic compounds, corresponding determination process and agents | |
| ES2113105T3 (es) | Reactivos para uso en bioluminiscencia. | |
| PT1267897E (pt) | Tratamento da insufuciencia cardiaca congestiva com sangue autologo previamente tratado | |
| JPS55500889A (enExample) | ||
| Hsi et al. | Characterization of a tyrosyl radical in prostaglandin endoperoxide synthase-2 | |
| CO4230066A1 (es) | Composiciones para el cuidado del cuerpo, metodo para usar- las y metodo para generar una suspension acuosa relativamen- te estable de silice coloidal para usarla en aquellas | |
| NZ503962A (en) | ACE inhibitor (angiotensin converting enzyme) and MMP (matrix metalloproteinase inhibitor) combinations for treating fibrosis | |
| ES2132355T3 (es) | Procedimiento de coloracion por oxidacion de las fibras queratinicas humanas con la ayuda de vapor de agua. | |
| WO1998023716A3 (en) | Enzymatic oxidation process | |
| WO2022217222A8 (en) | Gene correction for rag2 deficiency in human stem cells | |
| Plesnicar et al. | Peroxidase associated with higher plant mitochondria | |
| ES2123753T3 (es) | Vectores retroviricos para el tratamiento de tumores y lineas celulares que los contienen. | |
| AR016945A1 (es) | Composicion oxidante y utilizaciones para la tintura, deformacion peremanente o para la decoloracion de fibras queratinicas | |
| PT84640B (pt) | Vector viral que contem um gene que codifica para uma das glicoproteinas (gp) do involucro do virus responsavel pela s.i.d.a. e anticorpos contra essas glicoproteinas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |